CSO Robert Fremeau, Ph.D. to present at the Autism Tree Foundation Global Neuroscience Conference
Featured article
Event
November 3, 2023, at the Sanford Consortium for Regenerative Medicine, La Jolla, CA
Article Summary
In a move to speed up drug discovery and development, Roach's mission is to create “replicas” of human tissues and organs that can then be broadly applied across the company.
Located in Roche’s headquarters of Basel, Switzerland, the institute aims to grow to 250 scientists and bioengineers over the next four years, while building out a network of academic collaborators around the world. It currently houses 80 people, a Roche spokesperson said.
The unit will be the “central pillar” of pRED’s 10 year strategy, the spokersperson said, and the company will make a sustained financial commitment “in the tens of millions.”
Human model systems such as 3D “organoids” derived from stem cells, Roche said, mirror human and disease biology more accurately than animal models and could help researchers identify drug targets that may not be spotted with conventional discovery approaches. Other major biopharma companies, such as Sanofi and Gilead, have partnered with biotechs on similar tech, but few have committed to initiatives of such scale (...)